Intelligence, decoded

How Eli Lilly Climbed to a Trillion Dollars (and Plans to Stay There)

Two drugs turned a pharmaceutical company into a trillion-dollar beast. But here's the thing: pharma history is littered with giants who built empires on a single blockbuster, only to watch them crumble when rivals showed up. So what's Eli Lilly actually doing differently?